1. Home
  2. AGX vs KYMR Comparison

AGX vs KYMR Comparison

Compare AGX & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Argan Inc.

AGX

Argan Inc.

HOLD

Current Price

$468.98

Market Cap

8.4B

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$121.05

Market Cap

10.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGX
KYMR
Founded
1961
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
10.6B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
AGX
KYMR
Price
$468.98
$121.05
Analyst Decision
Buy
Strong Buy
Analyst Count
6
26
Target Price
$409.50
$107.72
AVG Volume (30 Days)
271.6K
637.1K
Earning Date
03-26-2026
04-30-2026
Dividend Yield
0.32%
N/A
EPS Growth
58.37
N/A
EPS
3.24
N/A
Revenue
$944,606,000.00
$39,211,000.00
Revenue This Year
$33.81
$10.61
Revenue Next Year
$20.97
$8.17
P/E Ratio
$154.82
N/A
Revenue Growth
8.06
N/A
52 Week Low
$197.00
$39.84
52 Week High
$805.75
$130.05

Technical Indicators

Market Signals
Indicator
AGX
KYMR
Relative Strength Index (RSI) 31.69 60.54
Support Level $401.98 $76.40
Resistance Level $492.70 $120.37
Average True Range (ATR) 29.14 4.60
MACD -7.30 0.88
Stochastic Oscillator 6.20 69.30

Price Performance

Historical Comparison
AGX
KYMR

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Teledata, out of which Power Services derives the majority of revenue.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Share on Social Networks: